Strides Arcolab to raise up to Rs 1,500 cr
The funds will be raised by way of issue of GDRs/ADRs /FCCBs/QIP or such other equity linked instruments Strides Arcolab plans to…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Strides Arcolab
Strides Arcolab acquires CNS divisions of erstwhile Ranbaxy
The agreement involves transfer of Ranbaxy’s Solus and Solus Care divisions, along with employees to Strides for a consideration…
Strides completes acquisition of Aspen’s generic biz in Australia
The acquired business will be integrated and consolidated with Strides effective September 1, 2015 Strides Arcolab has completed…
Strides Arcolab posts Q1 FY16 results
In Q1 FY16, pharma revenues were up six per cent YoY at Rs 2,761 million Strides Arcolab posted its financial results for the…
Strides inks agreements with Aspen Pharmacare Holdings
To acquire a generic pharma business in Australia and related assets from Aspen for approximately A$380 million
Strides inks agreements with Aspen Pharmacare Holdings
To acquire a generic pharma business in Australia and related assets from Aspen for approximately A$380 million
Strides Arcolab receives ANDA approval from US FDA
Product to be launched immediately Strides Arcolab has received approval from the United States Food & Drug Administration…
Strides Arcolab receives ANDA approval from US FDA
Polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution will be manufactured at the…
Strides Arcolab, Gilead Sciences agreement
To manufacture and distribute Tenofovir Alafenamide (TAF) based HIV treatments in 112 developing countries
Strides Arcolab receives US FDA approval for Calcitriol Softgel capsules
Product to be launched shortly